PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 22 hours 11 minutes
Reducing Errors and Elevating Care in HER2-Positive Metastatic Breast Cancer
Reducing Errors and Elevating Care in HER2-Positive Metastatic Breast Cancer
Keeping the Momentum in Metastatic Melanoma Therapy: Insights From ESMO 2014 on Novel Strategies and Implications for Canadian Practice
Go online to www.peervoice.com/h/pvs63 to view the entire programme with slides.
Insights and Strategies for Individualising Therapy for ALK-Positive NSCLC: Updates From Recent Medical Congresses
Go online to www.peervoice.com/h/pvs65 to view the entire programme with slides.
Breakthroughs and Game-Changers in NSCLC Management: Expert Perspectives on Current Evidence and Practice
Go online to www.peervoice.com/h/pve60 to view the entire programme with slides.
Expert Perspectives on Managing HER2-Positive Metastatic Breast Cancer: Updates from ESMO 2014 Implications for Canadian Practice
Go online to www.peervoice.com/h/pvs64 to view the entire programme with slides.
Can We Accelerate Advances in Pancreatic Cancer? Applying Today's Best Evidence to Improve the Potential for Tomorrow
Go online to www.peervoice.com/h/pve59 to view the entire programme with slides.
Pharmacologists and Oncologists Working Together to Define the Role of Biosimilars in Clinical Practice
Go online to www.peervoice.com/h/pvr154 to view the entire programme with slides.
Optimising Outcomes With Targeted Agents in HER2-Positive Metastatic Breast Cancer: Weighing the Options for Second-Line Therapy and Beyond
Go online to www.peervoice.com/h/pve51 to view the entire programme with slides.
Second-Line Treatment Options for Advanced Lung Adenocarcinoma: Data-Driven Decision-Making
Go online to www.peervoice.com/h/pve47 to view the entire programme with slides.
From Bench to Bedside: Updates in the Management of Haematologic Malignancies
From Bench to Bedside: Updates in the Management of Haematologic Malignancies